Pharsight

Drugs that contain Terbinafine Hydrochloride

1. Lamisil At patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5681849 KARO HLTHCARE Pharmaceutical composition for topical applications
Oct, 2014

(9 years ago)

US5681849

(Pediatric)

KARO HLTHCARE Pharmaceutical composition for topical applications
Apr, 2015

(9 years ago)

Market Authorisation Date: 17 March, 2000

Treatment: NA

Dosage: SPRAY;TOPICAL

More Information on Dosage

LAMISIL AT family patents

Family Patents